MATRIX PHARMACEUTICALS ApS: Financial statements 2024
CVR: 29625867
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
MATRIX PHARMACEUTICALS ApS (CVR 29625867) has filed annual accounts for 2024. In 2024, the company reported revenue of DKK 980,760 and a net result of DKK 440,028 compared with DKK 544,125 the year before. That is a decrease of 17.8% compared with the year before. The profit margin was 44.9%. Equity in the 2024 report amounted to DKK 59,972. The solvency ratio was 22.3%. The company had 1 employee in the financial year.
- Revenue
- DKK 980,760
- Gross Profit
- DKK 509,368
- Profit/Loss
- DKK 440,028
- Equity
- DKK 59,972
- Total Assets
- DKK 269,270
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | 981 t. | 509 t. | 440 t. | 60 t. | 1 |
| 2023 | 1.2 mio. | 1.2 mio. | 544 t. | -44 t. | - |
| 2022 | 1.2 mio. | 1.2 mio. | 580 t. | -80 t. | - |
| 2021 | - | 843 t. | 776 t. | -678 t. | 1 |
| 2020 | - | 849 t. | 731 t. | -1.5 mio. | 1 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
MATRIX PHARMACEUTICALS ApS has published its annual report for 2023. Revenue came to DKK 1,193,100, and the net result was DKK 544,125.
About MATRIX PHARMACEUTICALS ApS
MATRIX PHARMACEUTICALS ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2006. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Karsten Høilund Skafte. The board consists of Karsten Høilund Skafte. The company is owned by Karsten Høilund Skafte and KHS HOLDING ApS. The company has 1 employee (2018). In 2025, the company reported revenue of DKK 1,090,380 and a net result of DKK 589,123 compared with DKK 440,028 the year before. Equity in the 2025 report amounted to DKK 589,123.